Anti-Human DAN

Pricing & Details

Product No.D349
Formats AvailableView All
Product Type
Polyclonal Antibody
Alternate Names
Differential Screening-Selected Gene Aberrative in Neuroblastoma, Neuroblastomal Candidate Region, Suppressor of Tumorigenicity, NO3
Prod No.
Add to cart
D349-25 µg
25 µg
In stock
Min: 1
Step: 1
D349-100 µg
100 µg
In stock
Min: 1
Step: 1
Contact Us For Academic mAb Advantage Pricing

Antibody Details

Product Details

Reactivity Species
Host Species
NS0-Derived Recombinant Human DAN
Endotoxin Level
<0.1 EU/µg as determined by the LAL method
This antigen affinity purified polyclonal antibody has been 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 containing 5.0% w/v trehalose with no calcium, magnesium, or preservatives present.
Storage and Handling
The lyophilized antigen affinity purified polyclonal antibody can be stored desiccated at -20°C to -70°C for twelve months from date of receipt. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody, aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. No detectable loss of activity was observed after six months.
Country of Origin
Next Day Ambient
Applications and Recommended Usage?
Quality Tested by Leinco
Western Blotting: To detect Human DAN this polyclonal antibody can be used at a concentration of 0.1-0.2 µg/ml. This polyclonal antibody should be used in conjunction with compatible second-step reagents such as PN:G505 and a chromogenic substrate such as PN:T343. The detection limit for Human DAN is 2 ng/lane under either reducing or non-reducing conditions. The sensitivity of detection may increase up to 50 fold when a chemiluminescent substrate is used.
Other Applications Reported In Literature ?
IHC (NBF/Par.): This antibody should give satisfactory staining results when used at a concentration of 10 µg/ml. The recommended secondary antibody for IHC is PN:G505. For chromogenic detection with high signal and low background use PN:D100 or PN:K107.
Blocking: This antibody will block 95% of the binding of 100 ng/ml of Recombinant Human BMP-4 to immobilized Recombinant Human DAN (100 μl of 2 μg/ml was coated in each well) in a functional ELISA. 50% inhibition occurs at an antibody concentration of approximately 6 - 24 μg/ml.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.


Goat Anti-Human Differential Screening-Selected Gene Aberrative in Neuroblastoma (DAN) recognizes Human DAN. This antigen affinity purified polyclonal antibody was purified using a proprietary chromatographic technique that includes covalently immobilizing the antigen proteins or peptides to agarose based beads. This purification method enhances specificity, reduces nonspecific binding of extraneous IgG and provides you with the most reliable reagent available for your early discovery research.
DAN is a secreted glycoprotein related to Xenopus laevis cerberus. It is being referred to also as DAND1 [DAN domain family member 1]. The gene has been described also as NO3 gene, which shows tumor suppressor activity in cells transformed by the src oncogene.1 DAN belongs to a gene family, termed CAN family, that includes the head-inducing factor Gremlin, Cerberus, PRDC.2 DAN and several other members of the can family act as antagonists of BMP and appear to block BMP signaling by preventing bone morphogenetic proteins from interacting with their receptors. DAN has recently been demonstrated to have a tumor-suppressive activity in vitro and may have an important role in regulation of the entry of cells into the S phase.3

Antigen Details

NCBI Gene Bank ID

References & Citations

1. Ozaki and Sakiyama, (1993) Proceedings of the National Academy of Sciences 90(7) 2593-2597
2. Pearce, JJH. et al. (1999) Developmental Biology 209: 98
3. Sakiyama, S. et al. Cancer Res. (1995): 895
General Western Blot Protocol
Prod No.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok